Last reviewed · How we verify
NCT05861622
Examining the Efficacy of a Novel Moisturizer Across Eight Weeks
NA trial testing Moisturizer in Skin Health in 38 participants. Completed in 30 January 2023.
30 January 2023
Quick facts
| Lead sponsor | Thu Brulé |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 38 |
| Start date | 13 October 2022 |
| Primary completion | 30 January 2023 |
| Estimated completion | 30 January 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Moisturizer — full drug profile →
Conditions studied
- Skin Health — all drugs for Skin Health →
Sponsor
Thu Brulé
Who can join
Adults 30 to 80, any sex, with Skin Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Skin moisture is critical to avoid long-term skin damage. Without the necessary moisture, skin is unlikely to have the properties most commonly associated with healthy skin. Recent research has recently highlighted that rambutan extract, niacinamide, and glycoin can all help promote skin moisture and health. To help people experience better skin health, Thu Brulé has developed a serum designed to be used twice daily. Specifically, the test product in this trial was designed to help moisturize the skin and help lock in that moisture. The purpose of this trial is to examine the efficacy of the test product across an eight-week hybrid trial. The outcomes of interest include participants' perceptions of skin health and photographs/images taken of the skin.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05861622
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Moisturizer
Trials testing the same drug.
- NCT05337423 — Photobiomodulation in the Treatment of Hand-foot Syndrome · NA · terminated
- NCT05698485 — The Effects of a 3-Part Skin Care Regimen on Facial Wrinkles and Biophysical Attributes · NA · unknown
- NCT05688527 — The Effects of a 5-Step Skin Regimen on Pigmentation and Appearance Related Biophysical Properties · NA · unknown
- NCT05562518 — GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therap · Phase 4 · active not recruiting
- NCT04479514 — Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy · Phase 2 · completed
Other recruiting trials for Skin Health
Currently open trials in the same condition.
- NCT07383974 — The Impact of 12 Week Retention of Nutrients on Skin and the Perception of Physical Health Status · NA · recruiting
- NCT07215689 — Effects of KSM-66 Ashwagandha® (300 mg) on Skin and Hair Health in Healthy Men and Women" · NA · recruiting
- NCT07133477 — A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function · NA · recruiting
- NCT06952959 — The Effects of Cosmetic Acupuncture · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05861622 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Thu Brulé
- Last refreshed: 17 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05861622.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing